In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Invesco Ltd’s stock clocked out at $28.16, up 4.53% from its previous closing price of $26.94. In other words, the price has increased by $4.53 from its previous closing price. On the day, 8.96 million shares were traded. IVZ stock price reached its highest trading level at $28.44 during the session, while it also had its lowest trading level at $26.94.
Ratios:
To gain a deeper understanding of IVZ’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.23 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.11. For the most recent quarter (mrq), Quick Ratio is recorded 0.98 and its Current Ratio is at 0.98. In the meantime, Its Debt-to-Equity ratio is 0.60 whereas as Long-Term Debt/Eq ratio is at 0.60.
On October 03, 2025, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $28.
TD Cowen Upgraded its Hold to Buy on July 21, 2025, while the target price for the stock was maintained at $25.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 31 ’25 when Sharp Douglas J sold 160,000 shares for $23.56 per share. The transaction valued at 3,768,832 led to the insider holds 192 shares of the business.
Sharp Douglas J bought 160,000 shares of IVZ for $3,768,838 on Oct 31 ’25. On Sep 10 ’25, another insider, Butcher Stephanie, who serves as the Senior Managing Director of the company, sold 103,192 shares for $22.12 each. As a result, the insider received 2,282,710 and left with 29,855 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IVZ now has a Market Capitalization of 12558340096 and an Enterprise Value of 16982515712. As of this moment, Invesco’s Price-to-Earnings (P/E) ratio for their current fiscal year is 19.12, and their Forward P/E ratio for the next fiscal year is 11.04. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.57. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.99 while its Price-to-Book (P/B) ratio in mrq is 1.14. Its current Enterprise Value per Revenue stands at 2.705 whereas that against EBITDA is 13.505.
Stock Price History:
The Beta on a monthly basis for IVZ is 1.66, which has changed by 0.5708455 over the last 52 weeks, in comparison to a change of 0.16067612 over the same period for the S&P500. Over the past 52 weeks, IVZ has reached a high of $27.48, while it has fallen to a 52-week low of $11.60. The 50-Day Moving Average of the stock is 13.14%, while the 200-Day Moving Average is calculated to be 42.17%.
Shares Statistics:
It appears that IVZ traded 5.16M shares on average per day over the past three months and 3957460 shares per day over the past ten days. A total of 445.09M shares are outstanding, with a floating share count of 442.10M. Insiders hold about 0.67% of the company’s shares, while institutions hold 92.32% stake in the company. Shares short for IVZ as of 1765756800 were 13753860 with a Short Ratio of 2.67, compared to 1763078400 on 12586136. Therefore, it implies a Short% of Shares Outstanding of 13753860 and a Short% of Float of 5.4.
Dividends & Splits
With its trailing 12-month dividend rate of 0.835, IVZ has a forward annual dividend rate of 0.83. Against a Trailing Annual Dividend Yield of 0.030994803. The stock’s 5-year Average Dividend Yield is 4.14. The current Payout Ratio is 69.23% for IVZ, which recently paid a dividend on 2025-11-14 with an ex-dividend date of 2025-11-14. Stock splits for the company last occurred on 2000-11-08 when the company split stock in a 25:10 ratio.
Earnings Estimates
A detailed examination of Invesco Ltd (IVZ) is currently in progress, with 8.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $0.56, with high estimates of $0.59 and low estimates of $0.52.
Analysts are recommending an EPS of between $2.02 and $1.93 for the fiscal current year, implying an average EPS of $1.98. EPS for the following year is $2.51, with 9.0 analysts recommending between $2.69 and $2.4.
Revenue Estimates
In. The current quarter, 3 analysts expect revenue to total $1.24B. It ranges from a high estimate of $1.25B to a low estimate of $1.23B. As of. The current estimate, Invesco Ltd’s year-ago sales were $1.16BFor the next quarter, 3 analysts are estimating revenue of $1.26B. There is a high estimate of $1.27B for the next quarter, whereas the lowest estimate is $1.25B.
A total of 3 analysts have provided revenue estimates for IVZ’s current fiscal year. The highest revenue estimate was $4.64B, while the lowest revenue estimate was $4.63B, resulting in an average revenue estimate of $4.64B. In the same quarter a year ago, actual revenue was $4.4BBased on 3 analysts’ estimates, the company’s revenue will be $5.31B in the next fiscal year. The high estimate is $5.38B and the low estimate is $5.23B.
